Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(33)
PROCEDURE(2)
DRUG(1)
Computed Tomography
8 trials
phase_1phase_2phase_3
jonsson-comprehensive-cancer-center
Positron Emission Tomography
8 trials
phase_1phase_2phase_3
jonsson-comprehensive-cancer-center
Gallium Ga 68 Gozetotide
3 trials
early_phase_1phase_1phase_2
jonsson-comprehensive-cancer-center
Gallium Ga 68 FAPi-46
3 trials
phase_1
jonsson-comprehensive-cancer-center
Questionnaire Administration
2 trials
phase_2
jonsson-comprehensive-cancer-center
Gallium Ga 68-labeled PSMA-11
2 trials
phase_2phase_3
jonsson-comprehensive-cancer-center
Single Photon Emission Computed Tomography
1 trial
phase_2
jonsson-comprehensive-cancer-center
Fludeoxyglucose F-18
1 trial
phase_1
jonsson-comprehensive-cancer-center

+8 more interventions

16 unique interventions3 categories

Analytics

Trial Phases

Phase 14
Phase 22
Phase 32

Trial Status

Completed1
Recruiting1
Terminated2
Other5

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT07118176Phase 1Active Not Recruiting
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
PrincipalinvestigatorStart date: 2025-08-01
NCT06216249Phase 2Recruiting
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
Prostate CarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
PrincipalinvestigatorStart date: 2024-08-01
NCT05160597Early Phase 1Active Not Recruiting
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
Prostate Carcinoma
PrincipalinvestigatorStart date: 2022-01-13
NCT04457232Phase 1Active Not Recruiting
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
Metastatic Malignant Neoplasm in the Prostate GlandProstate CarcinomaRecurrent Prostate Carcinoma
PrincipalinvestigatorStart date: 2020-09-09
NCT04459273Phase 1Active Not Recruiting
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Bladder CarcinomaCancer of Unknown Primary SiteCervical Carcinoma+13 more
PrincipalinvestigatorStart date: 2020-08-27
NCT04457245Phase 3Terminated
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+6 more
PrincipalinvestigatorStart date: 2020-08-14
NCT04279561Phase 1Terminated
Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8+2 more
PrincipalinvestigatorStart date: 2020-04-16
NCT03582774Phase 3Active Not Recruiting
Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy
Recurrent Prostate Carcinoma
PrincipalinvestigatorStart date: 2018-07-12
NCT04050215Phase 2Completed
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+6 more
PrincipalinvestigatorStart date: 2018-04-02

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Castration-Resistant Prostate CarcinomaProstate AdenocarcinomaMetastatic Prostate Carcinoma+6 more

Worked with same sponsors:

National Cancer Institute (NCI)Prostate Cancer Foundation
Similarity Score4%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Colorectal CancerCholangiocarcinomaCarcinoma, Hepatocellular+1 more
Similarity Score2%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

CholangiocarcinomaColorectal CancerCarcinoma, Hepatocellular+1 more
Similarity Score2%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCholangiocarcinomaColorectal Cancer
Similarity Score1%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCholangiocarcinomaColorectal Cancer
Similarity Score1%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal CancerProstate Adenocarcinoma
Similarity Score1%

Tim F Greten, M.D.

National Cancer Institute (NCI)

Related
22 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal CancerCholangiocarcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal CancerSarcoma
Similarity Score1%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Brain CancerSarcoma
Similarity Score1%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Colorectal CancerBrain Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT07118176Phase 1PrincipalInvestigator

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Active Not Recruiting
NCT06216249Phase 2PrincipalInvestigator

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Prostate CarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Recruiting
NCT05160597Early Phase 1PrincipalInvestigator

Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy

Prostate Carcinoma
Active Not Recruiting
NCT04457232Phase 1PrincipalInvestigator

Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation

Metastatic Malignant Neoplasm in the Prostate GlandProstate CarcinomaRecurrent Prostate Carcinoma
Active Not Recruiting
NCT04459273Phase 1PrincipalInvestigator

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Bladder CarcinomaCancer of Unknown Primary SiteCervical Carcinoma+13 more
Active Not Recruiting
NCT04457245Phase 3PrincipalInvestigator

Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer

Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+6 more
Terminated
NCT04279561Phase 1PrincipalInvestigator

Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer

Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8+2 more
Terminated
NCT03582774Phase 3PrincipalInvestigator

Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy

Recurrent Prostate Carcinoma
Active Not Recruiting
NCT04050215Phase 2PrincipalInvestigator

68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer

Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+6 more
Completed

All 9 trials loaded